The efficacy of eucalyptus essence inhalation in hospitalized patients with COVID-19
Phase 3
- Conditions
- COVID -19 disease.
- Registration Number
- IRCT20201127049507N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
People with a diagnosis of COVID -19 and hospitalization in general wards
Having the necessary ability to conduct studies
Involvement of lung tissue according to CT scan
In both sexes men and women in the age group of 18 to 70 years who have recently been admitted
Have signed the informed consent form to participate in the study
They do not participate in another clinical trial at the same time
Exclusion Criteria
History of previous illness
Pregnancy and lactation
Serious heart and lung disease
Blood pressure above 160 mm Hg
history of allergic symptoms
Consumption of herbal perfumes as well as synthetic sprays effective on airway obstruction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Arterial oxygen saturation. Timepoint: Every 24 hours. Method of measurement: With pulse oximetry device.;Respiratory rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Blood pressure. Timepoint: every 24 hours. Method of measurement: By monitoring device.;Heart rate. Timepoint: every 24 hours. Method of measurement: By monitoring device.;White blood cells. Timepoint: every 24 hours. Method of measurement: Perform a complete blood count test.;Fever. Timepoint: every 24 hours. Method of measurement: By thermometer device.
- Secondary Outcome Measures
Name Time Method